06:19:07 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Pure Extracts Technologies Corp
Symbol PULL
Shares Issued 116,766,811
Close 2023-04-28 C$ 0.01
Market Cap C$ 1,167,668
Recent Sedar+ Documents

Pure Extracts seeks bankruptcy protection

2023-08-28 17:33 ET - News Release

Subject: Pure Extracts - News Release Word Document File: '\\swfile\EmailIn\20230828 140859 Attachment PULL NR_08_25_23_ Appointment of Bankruptcy Trustee.docx' Vancouver, B.C. (August 28, 2023 -- GLOBE NEWSWIRE) - Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) ("Pure Extracts" or the "Company") announces today that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp. (the "Subsidiary"), has filed an Assignment in Bankruptcy under the Bankruptcy and Insolvency Act (Canada). The Subsidiary is no longer able to meet its financial obligations and has appointed Pricewaterhouse Coopers Inc. as its Licensed Insolvency Trustee to seek settlement with its creditors. The Company also announces that Yana Popova has tendered her resignation as Chief Financial Officer, Corporate Secretary and a director of the Company and Sean Bromley has tendered his resignation as a director of the Company, effective immediately. ON BEHALF OF THE BOARD "Doug Benville" Doug Benville Interim CEO and Director About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company's stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020. Find out more at https://pureextractscorp.com/ Or contact: Pure Extracts Investor Relations Tel: +1 604 493 2052 info@pureextractscorp.com This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts', are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk Factors" in the Company's Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws. The CSE has neither approved nor disapproved the contents of this press release.

© 2026 Canjex Publishing Ltd. All rights reserved.